日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activation of the PERK branch of the unfolded protein response during production reduces specific productivity in CHO cells via downregulation of PDGFRa and IRE1a signaling

生产过程中未折叠蛋白反应的 PERK 分支的激活会通过下调 PDGFRa 和 IRE1a 信号降低 CHO 细胞中的特定生产力

Brian M Castellano, Danming Tang, Scot Marsters, Cynthia Lam, Peter Liu, Christopher M Rose, Wendy Sandoval, Avi Ashkenazi, Brad Snedecor, Shahram Misaghi

An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1

一项间接比较多替拉韦联合拉米夫定与基于第二代整合酶抑制剂的三药单片方案在初治 HIV-1 感染者中 144 周疗效、安全性和耐受性的研究

Evitt, Lee A; Nanji, Sakina; Grove, Richard A; Okoli, Chinyere; van Wyk, Jean; Snedecor, Sonya J

Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up

左旋多巴-卡比多巴肠凝胶对运动障碍及睡眠等非运动症状的影响:一项为期24个月的荟萃分析结果

Chaudhuri, K Ray; Antonini, Angelo; Pahwa, Rajesh; Odin, Per; Titova, Nataliya; Thakkar, Sandeep; Snedecor, Sonya J; Hegde, Saket; Alobaidi, Ali; Parra, Juan Carlos; Zadikoff, Cindy; Bergmann, Lars; Standaert, David G

Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection

间接比较每 8 周一次的长效卡博特韦和利匹韦林维持治疗与每日口服标准抗逆转录病毒疗法在病毒学抑制的 HIV-1 感染患者中的 48 周疗效和安全性

Chounta, Vasiliki; Snedecor, Sonya J; Wu, Sterling; Van de Velde, Nicolas

Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review

贝利木单抗治疗系统性红斑狼疮的真实世界疗效:系统性文献综述

Huang, Shirley P; Snedecor, Sonya J; Nanji, Sakina; Lloyd, Emily; Bell, Christopher F

Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

更正:美国人乳头瘤病毒癌症死亡造成的生产力损失的经济价值

Priyadarshini, Masoom; Prabhu, Vimalanand S; Snedecor, Sonya J; Corman, Shelby; Kuter, Barbara J; Nwankwo, Chizoba; Chirovsky, Diana; Myers, Evan

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

多替拉韦与常用核心药物在初治 HIV-1 感染患者中的疗效、安全性和持久性比较:系统评价和网络荟萃分析的最新进展

Nickel, Katharina; Halfpenny, Nicholas J A; Snedecor, Sonya J; Punekar, Yogesh Suresh

Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

更正:多替拉韦与常用核心药物在初治 HIV-1 感染患者中的疗效、安全性和持久性比较:系统评价和网络荟萃分析的最新进展

Nickel, Katharina; Halfpenny, Nicholas J A; Snedecor, Sonya J; Punekar, Yogesh Suresh

Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis

静脉注射维多珠单抗与皮下注射阿达木单抗治疗中重度活动性溃疡性结肠炎的成本效益分析

Schultz, Bob G; Diakite, Ibrahim; Carter, John A; Snedecor, Sonya J; Turpin, Robin

UBR E3 ligases and the PDIA3 protease control degradation of unfolded antibody heavy chain by ERAD

UBR E3 连接酶和 PDIA3 蛋白酶控制 ERAD 对未折叠抗体重链的降解

Danming Tang, Wendy Sandoval, Cynthia Lam, Benjamin Haley, Peter Liu, Di Xue, Deepankar Roy, Tom Patapoff, Salina Louie, Brad Snedecor, Shahram Misaghi